Quantum criticality and entropy transfer in spin chains and planes—Pyridine oxide copper salts von Trinh, Jennifer, Schaller, Daniel, LaBarre, Patrick G., Schlenker, Kevin, Miller, Joel S., Ramirez, Arthur P.

Volltext

Role of Ligand-Bound CO2 in the Hydrogenation of CO2 to Formate with a (PNP)Mn Catalyst von Schlenker, Kevin, Christensen, Elizabeth G, Zhanserkeev, Asylbek A, McDonald, Gabriel R, Yang, Emily L, Lutz, Kevin T, Steele, Ryan P, VanderLinden, Ryan T, Saouma, Caroline T

Volltext

Role of Ligand-Bound CO 2 in the Hydrogenation of CO 2 to Formate with a (PNP)Mn Catalyst von Schlenker, Kevin, Christensen, Elizabeth G., Zhanserkeev, Asylbek A., McDonald, Gabriel R., Yang, Emily L., Lutz, Kevin T., Steele, Ryan P., VanderLinden, Ryan T., Saouma, Caroline T.

Volltext

Large changes in hydricity as a function of charge and not metal in (PNP)M-H (de)hydrogenation catalysts that undergo metal-ligand cooperativity von Schlenker, Kevin, Casselman, Lillee K, VanderLinden, Ryan T, Saouma, Caroline T

Volltext

Quantum criticality and entropy transfer in spin chains and planes—Pyridine oxide copper salts von Trinh, Jennifer, Schaller, Daniel, LaBarre, Patrick G., Schlenker, Kevin, Miller, Joel S., Ramirez, Arthur P.

Volltext

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases von Flaherty, Kevin R, Wells, Athol U, Cottin, Vincent, Devaraj, Anand, Walsh, Simon L.F, Inoue, Yoshikazu, Richeldi, Luca, Kolb, Martin, Tetzlaff, Kay, Stowasser, Susanne, Coeck, Carl, Clerisme-Beaty, Emmanuelle, Rosenstock, Bernd, Quaresma, Manuel, Haeufel, Thomas, Goeldner, Rainer-Georg, Schlenker-Herceg, Rozsa, Brown, Kevin K

Volltext

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis von Richeldi, Luca, du Bois, Roland M, Raghu, Ganesh, Azuma, Arata, Brown, Kevin K, Costabel, Ulrich, Cottin, Vincent, Flaherty, Kevin R, Hansell, David M, Inoue, Yoshikazu, Kim, Dong Soon, Kolb, Martin, Nicholson, Andrew G, Noble, Paul W, Selman, Moisés, Taniguchi, Hiroyuki, Brun, Michèle, Le Maulf, Florence, Girard, Mannaïg, Stowasser, Susanne, Schlenker-Herceg, Rozsa, Disse, Bernd, Collard, Harold R

Volltext

Nintedanib in Patients With Autoimmune Disease–Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial von Matteson, Eric L., Kelly, Clive, Distler, Jörg H. W., Hoffmann‐Vold, Anna‐Maria, Seibold, James R., Mittoo, Shikha, Dellaripa, Paul F., Aringer, Martin, Pope, Janet, Distler, Oliver, James, Alexandra, Schlenker‐Herceg, Rozsa, Stowasser, Susanne, Quaresma, Manuel, Flaherty, Kevin R.

Volltext

The natural history of progressive fibrosing interstitial lung diseases von Brown, Kevin K, Martinez, Fernando J, Walsh, Simon L F, Thannickal, Victor J, Prasse, Antje, Schlenker-Herceg, Rozsa, Goeldner, Rainer-Georg, Clerisme-Beaty, Emmanuelle, Tetzlaff, Kay, Cottin, Vincent, Wells, Athol U

Volltext

Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic Criteria von Raghu, Ganesh, Wells, Athol U, Nicholson, Andrew G, Richeldi, Luca, Flaherty, Kevin R, Le Maulf, Florence, Stowasser, Susanne, Schlenker-Herceg, Rozsa, Hansell, David M

Volltext

Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases von Brown, Kevin K., Inoue, Yoshikazu, Flaherty, Kevin R., Martinez, Fernando J., Cottin, Vincent, Bonella, Francesco, Cerri, Stefania, Danoff, Sonye K., Jouneau, Stephane, Goeldner, Rainer‐Georg, Schmidt, Martin, Stowasser, Susanne, Schlenker‐Herceg, Rozsa, Wells, Athol U.

Volltext

Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials von Richeldi, Luca, Cottin, Vincent, du Bois, Roland M, Selman, Moisés, Kimura, Toshio, Bailes, Zelie, Schlenker-Herceg, Rozsa, Stowasser, Susanne, Brown, Kevin K

Volltext

Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial von Flaherty, Kevin R, Wells, Athol U, Cottin, Vincent, Devaraj, Anand, Inoue, Yoshikazu, Richeldi, Luca, Walsh, Simon L F, Kolb, Martin, Koschel, Dirk, Moua, Teng, Stowasser, Susanne, Goeldner, Rainer-Georg, Schlenker-Herceg, Rozsa, Brown, Kevin K

Volltext

Geriatric dermatologic surgery part II: Peri- and intraoperative considerations in the geriatric dermatologic surgery patient von Savage, Kevin T., Chen, Jeffrey, Schlenker, Kathryn, Pugliano-Mauro, Melissa, Carroll, Bryan T.

Volltext

Geriatric dermatologic surgery part I: Frailty assessment and palliative treatments in the geriatric dermatology population von Savage, Kevin T., Chen, Jeffrey, Schlenker, Kathryn, Pugliano-Mauro, Melissa, Carroll, Bryan T.

Volltext

Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis von Wu, Xiaoping, Kim, Grace H, Salisbury, Margaret L, Barber, David, Bartholmai, Brian J, Brown, Kevin K, Conoscenti, Craig S, De Backer, Jan, Flaherty, Kevin R, Gruden, James F, Hoffman, Eric A, Humphries, Stephen M, Jacob, Joseph, Maher, Toby M, Raghu, Ganesh, Richeldi, Luca, Ross, Brian D, Schlenker-Herceg, Rozsa, Sverzellati, Nicola, Wells, Athol U, Martinez, Fernando J, Lynch, David A, Goldin, Jonathan, Walsh, Simon L F

Volltext

Reply to comment on "The natural history of progressive fibrosing interstitial lung diseases" von Brown, Kevin K, Schlenker-Herceg, Rozsa, Wells, Athol U

Volltext

Effects of nintedanib by inclusion criteria for progression of interstitial lung disease von Maher, Toby M, Brown, Kevin K, Kreuter, Michael, Devaraj, Anand, Walsh, Simon L F, Lancaster, Lisa H, Belloli, Elizabeth A, Padilla, Maria, Behr, Juergen, Goeldner, Rainer-Georg, Tetzlaff, Kay, Schlenker-Herceg, Rozsa, Flaherty, Kevin R

Volltext

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-bli... von Flaherty, Kevin R, Brown, Kevin K, Inoue, Yoshikazu, Moua, Teng, Crestani, Bruno, Wuyts, Wim A, Stowasser, Susanne, Quaresma, Manuel, Goeldner, Rainer-Georg, Schlenker-Herceg, Rozsa, Kolb, Martin, Aburto, M., Acosta, O., Antin-Ozerkis, D., Arce, G., Barczyk, A., Bascom, R., Bazdyrev, E., Belloli, E., Bergna, M.A., Blaas, S., Bondue, B., Bonella, F., Cantin, A., Castillo Villegas, D.M., Cazaux, A., Cerri, S., Cottin, V., Crestani, B., Dahlqvist, C., Danoff, S., Dematte D'Amico, J., Dilling, D., Elias, P., Falk, J., Fernández Pérez, E.R., Gamez-Dubuis, A., Giessel, G., Glassberg, M., Glazer, C., Guiot, J., Hirani, N., Homik, L., Hope-Gill, B., Hotchkin, D., Ilkovich, M., Inoue, Y., Jassem, E., Jones, L., Kitamura, H., Kolb, M., Kono, C., Kulkarni, T., León Jiménez, A., Luo, Q., Mageto, Y., Maher, T.M., Makino, S., Martinez, R., Martínez, M., Miyazaki, Y., Morrison, L., Morrow, L., Moua, T., Nambiar, A., Nunes, H., Okamoto, M., Otaola, M., Park, J.S., Patel, N., Pesci, A., Poonyagariyagorn, H., Quadrelli, S., Randerath, W., Reynaud-Gaubert, M., Rosas, I., Safdar, Z., Saito, T., Sakamoto, N., Schmidt, S., Scholand, M.B., Shapera, S., Shlobin, O., Sigal, B., Silva Orellana, A., Song, J.W., Stone, H., Sugiura, H., Takaya, H., Takeuchi, T., Thavarajah, K., Tolle, L., Tomii, K., Valenzuela, C., Vancheri, C., Varone, F., Veeraraghavan, S., Wemeau, L., Yakusevich, V., Yamada, Y.

Volltext

Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease von Flaherty, Kevin R, Brown, Kevin K, Wells, Athol U, Clerisme-Beaty, Emmanuelle, Collard, Harold R, Cottin, Vincent, Devaraj, Anand, Inoue, Yoshikazu, Le Maulf, Florence, Richeldi, Luca, Schmidt, Hendrik, Walsh, Simon, Mezzanotte, William, Schlenker-Herceg, Rozsa

Volltext